AstraZeneca has admitted that its COVID-19 vaccine could cause a rare but deadly blood-clotting condition, potentially exposing the UK pharmaceutical giant to tens of millions in lawsuits brought by ...

After another swing and a miss for AstraZeneca's Fasenra in chronic obstructive pulmonary disease (COPD), the company is pivoting to other options in its portfolio that might have potential to treat ...

A multi-million-pound landmark “vaccine damage” case is set to take place in London’s High Court. The test case is being pursued by Jamie Scott who suffered a severe brain injury in April 2021 after ...

AstraZeneca received FDA clearance to expand Breztri’s use to asthma patients aged 12 and older and to offer at-home self-injection for Saphnelo in lupus treatment. It also began an FDA-supported real ...

The U.S. Food and Drug Administration (FDA) on Monday approved AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) in combination with pertuzumab for patients with a ...

The FDA has approved AstraZeneca’s Saphnelo autoinjector for subcutaneous self-administration in adults with moderate to severe systemic lupus erythematosus (SLE) receiving standard therapy. The ...

The FDA is looking at a slew of label expansions this month, including one that could open up home-based treatments for ...